A ngiogenesis is critical in vasculoproliferative processes, including tumor growth, and inflammatory states such as psoriasis and rheumatoid arthritis (RA) 3 (1). Endothelial cells (ECs) initiate and regulate the inflammatory response by releasing chemoattractants, expressing adhesion molecules, and participating in cell-cell interactions with circulating leukocytes and other ECs (2) . EC interactions with circulating leukocytes and other ECs play an essential role in the development of both inflammation and neovascularization (3) (4) (5) .
The structural elements of carbohydrate moieties are built by sequential addition of saccharide units on the luminal side of the Golgi apparatus by specific glycosyltransferases. Blood group Ags can be divided into type 1 and type 2 chain blood group ABH Ags, Lewis Ags, and X/Y glycolipid Ags, each distinguished by characteristic carbohydrate sequence, binding position, and linkage anomericity (6) . Lewis determinants are structurally related to determinants of the ABH blood group system and are comprised of two major Ags, Le a and Le b . Lewis and related Ags may occur 1) as free oligosaccharides, a typical occurrence in milk and urine; 2) protein bound by an O-linkage via an N-acetylgalactosamine to a serine or threonine residue; or 3) as glycolipids located mainly in the outer leaflet of the plasma membrane (6, 7) . A major site of Lewis plasma glycolipid synthesis is the digestive tract. Here, mucosal cells shed these Ags into the intestinal lumen, where they are digested, reabsorbed, and transported to the plasma. Circulating Lewis glycolipids in plasma can then be acquired by red cells, lymphocytes, and platelets (7) . Transfusion laboratories focus on Le a and Le b as the only two components of the Lewis blood group system; however, fucosylation of these Ags produces Lewis isomers, which include Le y . Numerous distinct ␣-(1,3)-fucosyltransferase genes have been cloned and characterized that can perform this function (8) . Although saccharide determinants that result from fucosyltransferase action do not appear significant in transfusion medicine, they may play a key role in lymphocyte traffic and inflammatory responses (9) .
We have shown that the soluble form of E-selectin mediates angiogenesis via its endothelial ligand, sialyl Le x (10, 11) . To further examine the EC function in inflammation, we raised a mAb, termed mAb 4A11, to adherent human RA synovial tissue (ST) cells (12) . 4A11 recognized the glycoconjugate Lewis y -6/H-5-2 (Le y /H), which is expressed mainly in inflamed and malignant disease states. These two sugars are structurally related, in that Le y is the result of fucose addition, by ␣-(1,3)-fucosyltransferase, to the nonterminal N-acetylglucosamine of H-5-2. To date, the species with which Le y /H is coupled is not fully elucidated. mAb 4A11 does not react with myeloid or lymphoid cell lines, platelets, macrophages, lymphocytes, or fibroblasts (13) . mAb 4A11 does, however, react with mature cultured human abdominal aortic ECs and, as we show here, with a subset of human dermal microvascular ECs (HMVECs). This mAb recognized the glycoconjugate Lewis y -6/H-5-2 (Le y /H), which shares some structural overlap with sialyl Le x . Le y /H is a selective Ag that is expressed on ECs only in synovium, lymphoid tissues, skin, and thymus as well as on epithelial cells such as keratinocytes (12, 14) . EC Le y /H expression is up-regulated before the ingress of inflammatory cells in vivo using a cytokine-dependent model of human poison ivy extract-induced contact dermatitis (12) . The biological role of glycoconjugates, such as Le y /H, which constitute the chemical basis for blood groups, has to date been poorly defined (6) . Here we show a role for glycoconjugates as novel mediators of angiogenesis.
Materials and Methods

Reagents
Anti-HLA class I was obtained from Biodesign (Kennebunk, ME). Sulfasalazine (SASP), TNF-␣, and IL-1␤ were obtained from Pharmacia-Upjohn (Kalamazoo, MI). Pepsin, trypsin, chymotrypsin, protease V8, proteinase K, ␤-galactosidase, neuraminidase, mannosidase, anti-mouse IgG, LPS, PMA, calcium ionophore A23187 (CIA), thrombin, histamine, BSA, hydrocortisone, tetramethylbenzidine, 2Ј-fucosyllactose (H-2g, the H analogue), anti-mouse IgM peroxidase conjugate, and anti-mouse IgG peroxidase conjugate were obtained from Sigma (St. Louis, MO). The 2Ј-fucosyllactose-BSA (H-2g-BSA) conjugate was purchased from V-Labs (Covington, LA). IL-4 was obtained from PeproTech (Rocky Hill, NJ). Endothelial growth medium, endothelial basal medium (EBM), and HMVECs were obtained from Clonetics (San Diego, CA). Mouse IgG and mouse IgM were purchased from Coulter (Hialeah, FL). Mouse anti-human von Willebrand factor (vWF) was obtained from PharMingen (San Diego, CA). Basic fibroblast growth factor (bFGF) was obtained from R&D Systems (Minneapolis, MN). Indomethacin was obtained from Cayman Chemical (Ann Arbor, MI). The vector ABC system was purchased from Vector (Burlingame, CA). Diaminobenzidine was obtained from Kirkegaard & Perry (Gaithersburg, MD). Diff-Quik was purchased from Baxter (North Chicago, IL). Lactodifucotetraose (Le y g; the Le y analogue) and H-disaccharide (HD; a short analogue of both Le y and H) were obtained from Accurate Chemical (Westbury, NY). Hydron was obtained from Interferon Sciences (New Brunswick, NJ). 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H7) was obtained from Seikagaku (Ijamsville, MD).
HMVEC stimulation for cell surface expression of Le y /H
HMVECs used in this study were between passage 5 and 11 and did not display discernable phenotypic changes when observed before each assay. Initial studies used a homogeneous population of Le y /H-expressing HMVECs sorted by flow cytometry, to optimize the sensitivity of the cellbased ELISA. Cells were incubated with or without immune modulators in RPMI plus 10% FBS for various times. Cells were fixed with 3.7% formalin in PBS (100 l/well) for 15 min. The plates were washed with PBS. mAb 4A11, mouse IgM, or anti-HLA class I (10 g/ml) diluted in wash buffer (PBS and 0.1% BSA) was added to each well (100 l/well) and incubated for 2 h. Plates were washed and blocked with 3% BSA in PBS (200 l/well) for 1 h. Plates were washed and urease-conjugated antimouse IgG diluted 1/1000 in wash buffer was added to each well for 1 h. Plates were washed with distilled water, combined with bromocresol purple substrate (50 l/well), and absorbance was read at 570 nm. Origins and concentrations of stimulants are indicated in the reagents section and figure legends, respectively.
After optimizing cell-based ELISA conditions, nonsorted HMVECs were plated in 96-well plates (5000 cells/well) and were grown to confluence in endothelial growth medium. Once confluent, the medium was changed to RPMI, 10% FBS, and 2 mM glutamine for 48 h. Cells were then incubated in the absence or the presence of stimuli for 20 min, medium was removed, and the cells were immediately fixed with 3.7% formalin in PBS (100 l/well) at 25°C for 15 min. The plates were washed with PBS and 0.05% Tween 20. Primary Ab (10 g/ml) diluted in PBS and 0.2% BSA was added to each well (100 l/well) and incubated for 2 h at 37°C. Primary Abs were: mAb 4A11, mouse anti-human vWF, mouse IgM (control), or mouse IgG (control). After washing, anti-mouse IgM peroxidase conjugate or anti-mouse IgG peroxidase conjugate was diluted in block buffer (100 l/well) and incubated for 1 h at 37°C. Following another wash, tetramethylbenzidine substrate was added to each well, and the reaction was terminated with 1 N H 2 SO 4 (50 l/well). Absorbance was read at 450 nm for quadruplicate samples. ELISA standards included either a mucin standard or an H-2g-BSA conjugate (V-Labs). The H-2g-BSA protein carries an average of seven moieties of 2Ј-fucosyllactose per protein (ranging from 4 -10 carbohydrate structures) as determined by laser desorption time of flight mass spectrometry.
Demonstration of Le y /H protease sensitivity
Human RA synovial tissue was digested with dispase, collagenase, and DNase for 2 h at 37°C (4). After filtration with a 40-m pore size nylon cell strainer, cells were resuspended in RPMI and 10% FBS and plated in polylysine-coated 96-well plates (1.25 ϫ 10 5 cells/well). Cells were spun down using microplate carriers and fixed with 0.25% glutaraldehyde or by air-drying at 37°C for 2 h. Cells were incubated with 0.1% BSA overnight and then treated with the following proteases for 2 h at 37°C: pepsin (280 U/ml), trypsin (308 U/ml), chymotrypsin (4.5 U/ml), protease V8 (100 U/ml), proteinase K (1.5 U/ml), ␤-galactosidase (100 U/ml), neuraminidase (2 U/ml), or mannosidase (3.6 U/ml). After washing (PBS and 0.1% Tween 20), plates were back-coated with 0.1% BSA for 2 h at 37°C followed by a 1-h incubation at 37°C with mAb 4A11 (10 g/ml). After additional washing, anti-mouse immunoperoxidase-conjugated Ab was incubated for 1 h at 37°C. After washing, and substrate addition, sulfuric acid was used to stop color development, and the plate was read at 490 nm. Each sample was assayed six times, and results are presented as the percent decrease in comparison with nonenzymatically treated tissue cells.
Detection of Le y /H by immunohistochemistry in ST
ST sections were fixed in acetone for 10 min at 4°C and rehydrated in PBS. mAb 4A11 (10 g/ml) was used as the primary Ab, with biotinylated anti-mouse IgM as a secondary Ab. A Vector ABC system containing avidin-HRP was used with diaminobenzidine as a substrate. Slides were counterstained with Gill's hematoxylin and Li 2 CO 3 for bluing and were dehydrated in ethanol.
Detection of Le y /H by immunofluorescence in HMVECs
HMVECs were fixed onto gelatin-coated glass coverslips by 20-min incubation in ice-cold acetone. Coverslips were blocked with 5% goat serum and incubated with mAb 4A11, rabbit anti-human vWF (IgG; Dako, Carpinteria, CA), or rabbit anti-human P-selectin (IgG; PharMingen, San Diego, CA) overnight at 4°C. 
Detection of soluble Le y /H in synovial fluid (SF) by ELISA
ELISA plates (96-well) were coated with 100 l/well mAb 4A11 (25 g/ml in 50 mM H 3 BO 3 and 120 mM NaCl, pH 8.6) for 2 h at 37°C and washed in PBS (pH 7.5) and 0.05% Tween 20. Nonspecific binding was blocked with 200 l/well 2% BSA in PBS (block buffer), for 90 min at 37°C. After washing, specimens or standards (mucin-containing Le y /H, Sigma) were added in duplicate, and plates were incubated for 3 h at 37°C. After washing, 100 l/well of a biotinylated form of the same 4A11 mAb (25 g/ml in block buffer) was added for 1 h at 37°C, and plates were washed. After adding peroxidase-conjugated avidin, the plates were incubated for 30 min at 37°C, and washed. Orthophenylenediamine dichloride substrate was added for a 6-to 8-min incubation, the reaction was terminated with 1 M H 2 SO 4 and read at 490 nm.
HMVEC chemotaxis induced by glucose analogues of Le y /H and purified H-5-2 and Le y glycolipids
Subconfluent HMVECs were fed the night before the assay. HMVECs (3.75 ϫ 10 4 cells/25 l EBM and 0.1% FBS) were placed in the bottom wells of 48-blind well chemotaxis chambers (NeuroProbe, Cabin John, MD) with gelatin-coated polycarbonate membranes (8 m pore size; Nucleopore, Pleasant, CA). Inverted chambers were incubated at 37°C for 2 h. Test substances, PBS, or positive control bFGF (60 nM) in PBS was added to the bottom wells, and the chambers were incubated for 2 h at 37°C. The membranes were removed, fixed in methanol, and stained with Diff-Quik. Test substances include Le y g, H-2g, and HD. HD was chemically synthesized and was Ͼ95% pure. Le y g and H-2g were purified from pooled human milk and were 95 and 99.1% pure, respectively. Three high power microscope fields were counted in each well. Checkerboard analyses were performed in a similar manner as chemotaxis assays, except that the concentrations of Le y g and H-2g were varied in the upper and lower chambers.
Immunodepletion of the glucose analogues with mAb 4A11 or mouse IgM control was accomplished by preincubation for 1 h at 37°C. Glucose analogues were immunodepleted at concentrations of 1 nM and 100 M with 50 g/ml of Ab. Upon completion of this neutralization period, the glucose analogue/Ab combination was assayed in the HMVEC chemotaxis assay.
In addition to performing chemotaxis with the glucose analogues of Le y and H structures, we performed HMVEC chemotaxis with H-5-2 and Lewis y -6 purified from dog small intestine (15) . Purified substances were dissolved in ethanol and diluted to a working concentration of 0.1% ethanol. All PBS and bFGF controls were likewise analyzed in 0.1% ethanol. HMVECs were Ͼ99% viable in 0.1% ethanol by trypan blue exclusion.
Le y g-and H-2g-induced HMVEC proliferation
HMVEC proliferation in response to Le y g, H-2g, and HD was determined using modifications of a procedure used previously (11) . Briefly, 2.5 ϫ 10 3 cells were allowed to adhere to 96-well plates for 2-4 h. Serial dilutions of glucose analogues or bFGF (positive control) were prepared, ranging from 0.1 pM to 100 M in EBM and 2% FBS in a 100-l volume. Quadruplicate samples were incubated at 37°C for 72 h. Relative cell numbers were determined using a Cell Titer 96 AQueous cell proliferation assay kit according to the manufacturer's protocol (Promega, Madison, WI). Absorbance was read at 490 nm on an ELISA plate reader.
Le y g-and H-2g-induced angiogenesis in vivo
In vivo corneal bioassays were performed as we have previously described (5) . Test substances were combined 1:1 with Hydron and implanted into the normally avascular corneal stroma of the rat several mm from the limbus (11) . Corneas were perfused with colloidal carbon after 7 days to provide a permanent record of the angiogenic response. Neutralization of glucose analogue-induced angiogenesis was performed by preincubating the glucose analogue with mAb 4A11 or IgM control for 1 h at 37°C. The glucose analogue/Ab combination was added to the Hydron pellet at a 1:1 ratio. H-2g or Le y g was analyzed at a final concentration of 50 M in combination with mAb 4A11 or control IgM at 25 g/ml. As a control, bFGF was likewise incubated with 25 g/ml mAb 4A11.
Statistical analysis
Statistical analysis was performed using one-way ANOVA followed by independent Student's t test; p Ͻ 0.05 was considered significant.
Results
Le y /H HMVEC cell surface expression and regulation
Cytokines may induce EC molecules, such as E-selectin, allowing the vasculature to play a central role in inflammation and angiogenesis (16) . We found that 42% of HMVECs were Le y /H immunopositive by flow cytometry. To determine whether Le y /H was inducible by cytokines or other immune modulators, Le y /H-positive HMVECs were treated with various stimuli for 5, 20, or 120 min. Le y /H was rapidly up-regulated on HMVECs by several immune modulators (Fig. 1) . Compared with nonstimulated cells, TNF-␣, LPS, and PMA significantly augmented Le y /H cell surface expression on the HMVECs after only 5 min (Fig. 1A) . After 20 min, all the stimuli significantly induced Le y /H cell surface expression compared with nonstimulated cells. CIA showed the greatest induction, increasing Le y /H expression Ͼ2-fold after 20 min of incubation (Fig. 1B) . TNF-␣, LPS, and IL-1␤ were also potent inducers of Le y /H; each showed about a 2-fold increase above nonstimulated cells. When the assays were repeated at 2 h (Fig. 1C) 
Storage of Le y /H in ECs
The rapid mobilization of Le y /H to the surface of HMVECs suggested that Le y /H was synthesized and stored ready for release upon stimulation. To investigate this possibility, we used immunofluorescence, which suggested mainly perinuclear vesicular storage of Le y /H in nonstimulated HMVECs ( Fig. 3A ; red ϭ Le y /H immunopositivity, blue ϭ Hoechst nuclear staining). Upon stimulation with IL-1␤ for 20 min, Le y /H localization appeared more uniformly distributed, suggesting cell membrane localization (Fig.  3B ). Dual staining (Fig. 3C ) demonstrated some overlap (yellow) storage of Le y /H (red) and vWF (green), as well as storage that appeared independent in the same cells. A similar colocalization pattern was found for Le y /H and P-selectin (data not shown). Negative control stains using an irrelevant IgM (Fig. 3D) or the combination of irrelevant IgM and IgG Abs displayed no prominent staining (data not shown).
Protease sensitivity of Le y /H
To determine whether Le y /H was attached to a protein moiety, we tested protease sensitivity. RA synovial tissue was enzymatically digested, and resultant cells were fixed and analyzed by cell-based ELISA with or without protease treatment. Trypsin, chymotrypsin, and protease V8 treatment reduced detectable levels of cell surface Le y /H by 39, 17, and 52%, respectively. In contrast, pepsin, proteinase K, ␤-galactosidase, neuraminidase, and mannosidase treatment had no effect on cell surface Le y /H levels (Fig. 4 , representative of three independent experiments). These results suggest that some portion of Le y /H is protein bound. These experiments cannot definitively determine whether partial inhibition is the result of an additional nonprotein Le y /H species or whether incomplete protein digestion occurred.
Expression of Le y /H in SF and ST
We have shown that the soluble adhesion molecule E-selectin mediates angiogenesis via its EC ligand sialyl Le x (11). Because sialyl Le x and Le y /H contain some structural overlap, we hypothesized that Le y /H may also be secreted in soluble form and mediate angiogenesis (11) . Using a sandwich ELISA, RA SF soluble Le y /H was significantly increased compared with noninflammatory OA SF ( Fig. 5A ; p Ͻ 0.05). Because mAb 4A11 was used for both capture and detection, this ELISA detected molecules containing multiple carbohydrate antigenic determinants. (Fig. 5D ) was typically less immunopositive. These results indicate that the Le y /H Ag is up-regulated in the angiogenic RA ST and SF, suggesting that it could play a role in neovascularization. Levels of soluble Le y /H contained in RA SF were compared with those required to induce HMVEC chemotaxis. Mean levels of soluble Le y /H in RA SF were equivalent to 5.2 pM H-2g-BSA, as determined using the H-2g-BSA standard in conjunction with the mAb 4A11 ELISA. Comparing to a standard of H-2g-BSA, RA SF contains ϳ36 pM soluble Le y /H. Purified glycolipids H-5-2 and Le y -6 can significantly chemoattract HMVECs at the concentrations of 1 pM and 1 fM, respectively, demonstrating that the levels found in RA SF are more than adequate to induce chemotaxis.
Regulation of HMVEC soluble Le y /H
To determine whether SF soluble Le y /H could occur via endothelial shedding and release we examined stimulation of cultured HMVECs and subsequent release of soluble Le y /H using an ELISA (Fig. 6 ). Soluble Le y /H was assayed in HMVEC-conditioned medium 5, 20, and 240 min after stimulation with or without irrelevant stimuli such as indomethacin, compared with stimuli such as TNF-␣, CIA, or IL-1␤. After 5 min, Le y /H levels were comparable with nonstimulated values (data not shown). After 20 min, however, TNF-␣, CIA, and IL-1␤ stimulation increased mean soluble Le y /H levels by 3.8-, 9.5-, and 5.4-fold, respectively, compared with equivalently stimulated conditioned medium after 5 min (Fig. 6A) . In contrast, conditioned medium from a control (human) skin fibroblast cell line (CRL 1635, American Type Culture Collection, Manassas, VA), not expected to produce soluble Le y /H, were not significantly altered compared with the nonstimulated baseline after TNF-␣, CIA, or IL-1␤ exposure (1.0-, 1.0-, and 1.3-fold change, respectively). Indomethacin, an irrelevant stimulus, had no effect on soluble Le y /H release. After 240 min (Fig.  6B) , mean soluble Le y /H levels in conditioned medium from HMVECs were increased 3. 
EC chemotaxis induced by Le y /H
To test the hypothesis that Le y /H was directly involved in neovascularization, we examined the involvement of Le y /H in EC chemotaxis in vitro, a facet of the angiogenic response, using glucose analogues of Le y and H structures (Fig. 7) (6, 17, 18) . Le y g stimulated chemotaxis of HMVECs at concentrations from 10 pM to 1 mM, inducing migration equivalent to 60 nM control angiogenic bFGF (Fig. 8A ). H-2g was likewise chemotactic for HMVECs from 10 pM to 1 mM, peaking at 1 M, also similar to the response induced by bFGF (Fig. 8B) . The shortest glucose analogue, HD, was not chemotactic for HMVECs (Fig. 8C) . The inability of HD, a structurally related glucose analogue (Fig. 7) , to induce HMVEC migration, demonstrates the specificity of the chemotactic function. Further, checkerboard analysis indicated that the effects of Le y g and H-2g were chemotactic (inducing directed migration), not chemokinetic (inducing random migration), for HMVECs (Fig. 9, A and B, respectively) . These results indicate that a minimal portion of the Le y /H structure is necessary for induction of endothelial chemotaxis. When Le y g and H-2g were preincubated with mAb 4A11, their chemotactic activity for HMVECs was significantly decreased ( p Ͻ 0.05; Fig. 10) . As a control, we induced chemotaxis with bFGF (60 nM) that was incubated with either mAb 4A11 (10 g/ml) or a mouse IgM control Ab (10 g/ml; Coulter). There was no difference when comparing mean cells migrating in response to bFGF and mAb 4A11 vs chemotaxis induced by bFGF and IgM (data not shown; n ϭ 6 and n ϭ 4, respectively), indicating that mAb 4A11 does not inhibit bFGF-induced EC chemotaxis. Next, we showed that purified Le y and H likewise induced chemotaxis of HMVECs in vitro, confirming that the results obtained using glucose analogues of Le y /H were similar to those obtained using purified Le y and H (Fig. 11) .
Le y /H EC proliferation assays
H-2g and Le y g did not induce HMVEC proliferation when assayed at concentrations ranging from 0.1 pM to 100 M compared with a vehicle control (n ϭ 3; data not shown). In contrast, a positive control concentration curve using bFGF induced significantly higher HMVEC proliferation at concentrations ranging from 0.1-100 nM, peaking at 10 nM (data not shown).
Angiogenesis induced by Le y /H
To determine whether Le y /H was angiogenic in vivo, Le y g, H-2g, and HD were assayed in the rat cornea (5, 11, 17) . Each test substance was incorporated into slow-release Hydron pellets and implanted into rat corneas (5, 11). H-2g induced an angiogenic response in 12 of 12 corneas (100% positive), and Le y g induced an angiogenic response in 15 of 16 corneas (94% positive; Fig. 12 , A and C, and Table I ). When H-2g was preincubated with mAb 4A11, the corneal angiogenic response was markedly reduced (one of seven positive corneas, or 14% positive corneal responses; Fig.  12B ). When Le y g was preincubated with mAb 4A11, the corneal angiogenic response was absent (zero of five positive, or 0% positive corneal responses; Fig. 12D ), indicating that mAb 4A11 immunoneutralized the effects of Le y g and H-2g and that Le y g and H-2g are potent angiogenic agents in vivo.
Discussion
In this study we characterize a novel EC glycoconjugate that is present in a subset of tissues, is cytokine inducible, is chemotactic for HMVECs in vitro in soluble form, and induces neovascularization. 
Le
y /H expression is stimulated on HMVECs by a number of immune modulators, indicating that Le y /H is a rapidly and transiently induced molecule, responsive to both cytokines and secretagogues. This rapid mobilization of Le y /H to the surface of HMVECs suggested that Le y /H was synthesized and stored ready for release upon stimulation, much like the adhesive EC molecule, P-selectin, which is stored in the Weibel-Palade bodies. P-selectin surface expression is rapidly induced on ECs after 5-10 min of histamine, CIA, or thrombin exposure (19, 20) . We demonstrate that the Le y /H Ag is rapidly cell surface expressed after similar cell stimulation. We also show that soluble Le y /H can be released from HMVECs by similar stimuli.
Further, we demonstrate the specificity of Le y /H expression on HMVECs using various specific immune modulators and demonstrate its induction relative to the characterized EC Ag vWF. Although thrombin, histamine, and bFGF induce both vWF and Le y /H expression on HMVECs, IL-4 and LPS up-regulate only Glycoconjugates (glycoproteins/glycolipids) have been known for some time to constitute the chemical basis for several blood group systems in man and to act as adhesion molecules for microbial ligands, although no physiological role has been shown for them until recently (6) . An mAb MIA-15-15, detecting Le y /Le x /H, inhibited the motility of tumor cells in vitro (22) . Because the potential of tumor cells for invasion is closely associated with motility, which appears to depend on specific glycosylation, it followed that patients bearing lung carcinomas identified by mAb MIA-15-15 had a strikingly worse prognosis than those whose tumors were MIA-15-15 negative (22) .
The importance of glycoconjugates in the induction of autoimmunity was recently underscored by the finding that Helicobacter pylori, the micro-organism involved in gastritis, ulcers, adenocarcinoma, and lymphoma of the stomach, expresses Le y /Le x /H, which is also found in gastric mucin (23, 24) . Mice bearing hybridomas making H. pylori-induced anti-Le Abs developed gastritis, pointing to a mechanism by which H. pylori participates in molecular mimicry. Hence, Abs directed against H. pylori Le y result in gastritis via an autoimmune reaction directed against gastric mucin Le y . In diseases such as RA, the inciting agent is unknown. Thus, it is possible that Le y /H may also trigger a molecular mimicry immune reaction in inflammatory angiogenic sites such as RA and psoriasis.
Glycoconjugates may play a role in cell adhesion and recruitment of cells into inflammatory sites. Sialyl Le x is a ligand for the endothelial adhesion molecules P-selectin and E-selectin (25) . The importance of glycoconjugates in inflammation has recently been described by Maly et al. (26) , who found that mice deficient in the enzymes that generate sialyl-Le x have a partial defect in neutrophil accumulation in response to an acute inflammatory stimulus.
The role of glycoconjugates and their ligands in angiogenesis is only recently becoming clear. Nguyen and co-workers identified a role for sialyl Le x in capillary morphogenesis (27) . We have shown that soluble E-selectin can act as an angiogenic mediator via interacting with its EC ligand sialyl Le x (11). Interestingly, there is an emerging concept of angiogenesis inhibitors, which suggests that they are also often stored in a preformed manner, as cryptic parts of larger molecules that are not themselves angiogenic. This may be the case with mediators such as the 29-kDa fragment of fibronectin, the 16-kDa fragment of prolactin, and angiostatin (a fragment of plasminogen), among others (28 -31) . However, an alternative paradigm concerning the regulation of angiogenesis by inducers and inhibitors may be that structural mimicry plays a role. Hence, a search based on crystal structure revealed that the angiogenic inhibitor endostatin was most homologous to the angiogenic mediator E-selectin (B. Olsen, data presented at the Angiogenesis in Cancer Meeting, Orlando, FL, 1998). Therefore, it is possible that a family of Le Ag-like molecules including Le y /H and their ligands, such as E-selectin, in the case of sialyl Le x , regulates angiogenesis via structural mimicry. Here, we show that glycoconjugate Le y /H, which shares some structural overlap with sialyl Le x , in the soluble form elicits an angiogenic response comparable to that induced by potent angiogenic factors such as vascular endothelial growth factor and bFGF (24, 25) .
One of the final steps in the biosynthesis of ABO blood group oligosaccharide Ags in vivo is catalyzed by ␣-(1,2)-fucosyltransferase(s) (32) . The H and secretor blood group loci determine the expression of these enzymes, which construct Fuc ␣162Gal␤-linkages (H determinants) that are essential precursors to the A and B Ags. Erythrocytes from rare Bombay blood group phenotype individuals are deficient in H determinants, and consequently A and B, the likely result of homozygosity for null alleles at the H locus (32) . To date, Bombay individuals have never been examined specifically for angiogenic deficits, probably because no biologic relevance of the H Ag has been determined (33) . However, such a defect may not be readily apparent, because molecular redundancy is common with regard to required biologic functions.
In summary, we have shown that Le y /H is a rapidly inducible molecule present at higher levels in RA ST compared with nonangiogenic OA ST and in RA SF compared with nonangiogenic OA SF. This suggests that Le y /H may play a contributing role in the process of inflammatory angiogenesis. This conclusion is further supported by the ability of the glucose analogues of Le y /H to induce cell migration in vitro and induce blood vessel growth in vivo. We hypothesize that upon cytokine or other immune modulator stimulation, Le y /H is rapidly expressed, shed from ECs, and subsequently exerts a direct angiogenic effect on adjacent ECs. These results suggest a novel function for blood group glycoconjugates, such as Le y /H, as angiogenic mediators. Efforts aimed at inhibiting the production or action of the Le y /H may curb the angiogenesis that characterizes conditions such as tumor growth, psoriasis, and RA.
